Iradimed Q1 2024 Earnings Report $52.41 -0.97 (-1.82%) As of 04:00 PM Eastern Earnings HistoryForecast Iradimed EPS ResultsActual EPS$0.32Consensus EPS $0.31Beat/MissBeat by +$0.01One Year Ago EPSN/AIradimed Revenue ResultsActual Revenue$17.60 millionExpected Revenue$17.26 millionBeat/MissBeat by +$340.00 thousandYoY Revenue GrowthN/AIradimed Announcement DetailsQuarterQ1 2024Date5/2/2024TimeN/AConference Call ResourcesPress ReleaseIRMD Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Powered by Remove Ads Iradimed Earnings HeadlinesIRADIMED CORPORATION To Participate at the 37th Annual Roth ConferenceMarch 10, 2025 | globenewswire.comIs Weakness In IRADIMED CORPORATION (NASDAQ:IRMD) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?March 4, 2025 | finance.yahoo.comElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.March 28, 2025 | Priority Gold (Ad)IRadimed Corporation (NASDAQ:IRMD) Q4 2024 Earnings Call TranscriptFebruary 17, 2025 | msn.comEarnings Update: Here's Why Analysts Just Lifted Their IRADIMED CORPORATION (NASDAQ:IRMD) Price Target To US$71.00February 16, 2025 | finance.yahoo.comiRadimed price target raised to $72 from $60 at Roth MKMFebruary 14, 2025 | markets.businessinsider.comSee More Iradimed Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Iradimed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Iradimed and other key companies, straight to your email. Email Address About IradimedIradimed (NASDAQ:IRMD) Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.View Iradimed ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss Upcoming Earnings Bank of New York Mellon (4/11/2025)BlackRock (4/11/2025)JPMorgan Chase & Co. (4/11/2025)Progressive (4/11/2025)Wells Fargo & Company (4/11/2025)Interactive Brokers Group (4/15/2025)Bank of America (4/15/2025)Citigroup (4/15/2025)Johnson & Johnson (4/15/2025)Morgan Stanley (4/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
